Filing Details

Accession Number:
0000711377-17-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-11 18:08:59
Reporting Period:
2017-01-09
Filing Date:
2017-01-11
Accepted Time:
2017-01-11 18:08:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188987 A Terri Morrical Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-09 16,200 $36.07 55,783 No 4 M Direct
Common Stock Acquisiton 2017-01-09 11,400 $39.61 67,183 No 4 M Direct
Common Stock Disposition 2017-01-09 27,600 $66.12 39,583 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2017-01-09 16,200 $0.00 16,200 $36.07
Common Stock Common Stock (Right to Buy) Disposition 2017-01-09 11,400 $0.00 11,400 $39.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
103,701 2018-08-30 No 4 M Direct
92,301 2019-10-31 No 4 M Direct
Footnotes
  1. Options were granted 8/30/2013, have five year lives, and vest in equal 20% annual installments on the first five anniversary dates of the grant
  2. Options were granted 10/1/2014, have five year lives, and vest in equal 20% annual installments on the first five anniversary dates of the grant.